---
title: "Supply of Anti D, Four Factor Concentrate and Hyper Immunes (AFHP)"
ocid: "ocds-r6ebe6-0000480471"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000480471"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000480471.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000480471.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"THE AUTHORITY\")"
published: "2017-06-09"
---

# Supply of Anti D, Four Factor Concentrate and Hyper Immunes (AFHP)

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY")  
Current stage: Award  
OCID: ocds-r6ebe6-0000480471

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000480471)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000480471.json)

## Summary

The Common Services Agency, known as NHS National Services Scotland, has initiated a tender for the "Supply of Anti D, Four Factor Concentrate and Hyper Immunes (AFHP)" in the health sector, focusing on goods. The procurement is currently in the Award stage, following a competitive open procedure. This framework agreement comprises seven categories (Lots) of products, all deliveries will be directed to the Scottish National Blood Transfusion Service in Edinburgh. The tender period ended on 27 March 2017, with the total contract value estimated at £8 million, including a potential 24-month extension.

This contract presents significant opportunities for suppliers in the healthcare sector, particularly those specialising in medical supplies, immunoglobulin products, and coagulation factors. Businesses with valid UK or EMA marketing authorisations for relevant medicines, as well as those certified with BS EN ISO 9001 or equivalent, are well-positioned to compete for this framework. Engaging in this tender could enhance suppliers’ visibility in the health market and establish long-term relationships with a pivotal authority in the sector.

## Notice

Supply of Anti D, Four Factor Concentrate and Hyper Immunes (AFHP). This Framework Agreement has been awarded in seven (7) categories, each of which is identified as a "Lot" as detailed in the contract notice. The Lots are as follows:- Lot 1 - Anti-D (Rho) Immunoglobulin Lot 2 - HBIG Hepatitis B Immunoglobulin Intramuscular use (IM) Lot 3 - HBIG Hepatitis B Immunoglobulin intravenous use (IV) Lot 4 - HTIG Tetanus immunoglobulin intramuscular use (IM) Lot 5 - Anti Rabies immunoglobulin for intramuscular use (IM) Lot 6 - VZIG Varicella - Zoster immunoglobulin intramuscular (IM) Lot 7 - Coagulation Factor Four Factor Prothrombin Complex Concentrate (PCC) All deliveries under the framework agreement will be to one central location, namely 'The Scottish National Blood Transfusion Service' (SNBTS), Edinburgh.

### Lot Information

HBIG Hepatitis B Immunoglobulin intramuscular use (IM)

Supply of HBIG Hepatitis B Immunoglobulin intramuscular use (IM)

Renewal: The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) separate periods of up to twelve (12) months by giving a minimum of three (3) months written notice of such extension.

HBIG Hepatitis B Immunoglobulin intravenous use (IV)

Supply of HBIG Hepatitis B Immunoglobulin intravenous use (IV)

Renewal: The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) separate periods of up to twelve (12) months by giving a minimum of three (3) months written notice of such extension.

HTIG Tetanus immunoglobulin intramuscular use (IM)

Supply of HTIG Tetanus immunoglobulin intramuscular use (IM)

Renewal: The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) separate periods of up to twelve (12) months by giving a minimum of three (3) months written notice of such extension.

Anti Rabies immunoglobulin for intramuscular use (IM)

Supply of Anti Rabies immunoglobulin for intramuscular use (IM)

Renewal: The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) separate periods of up to twelve (12) months by giving a minimum of three (3) months written notice of such extension.

VZIG Varicella - Zoster immunoglobulin intramuscular use (IM)

Supply of VZIG Varicella - Zoster immunoglobulin intramuscular use (IM)

Renewal: The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) separate periods of up to twelve (12) months by giving a minimum of three (3) months written notice of such extension.

Coagulation Factor Four Factor Prothrombin Complex Concentrate (PCC)

Supply of Coagulation Factor Four Factor Prothrombin Complex Concentrate (PCC) in a range of vials.

Renewal: The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) separate periods of up to twelve (12) months by giving a minimum of three (3) months written notice of such extension.

Anti-D (Rho) Immunoglobulin

Supply of Anti-D (Rho) Immunoglobulin either in a pre-filled syringe or vial.

Renewal: The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) separate periods of up to twelve (12) months by giving a minimum of three (3) months written notice of such extension.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUN285759 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Not specified |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 9 Jun 2017 |
| Submission deadline | 27 Mar 2017 |
| Future notice date | Not specified |
| Award date | 17 May 2017 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £8,000,000 |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY") |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33141510 - Blood products
- 33141520 - Plasma extracts
- 33600000 - Pharmaceutical products

## Release History

- 9 Jun 2017 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUN285759
- 23 Feb 2017 at 00:00 - Tender - OJEU - F2 - Contract Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB274757

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB274757
  Supply of Anti D, Four Factor Concentrate and Hyper Immunes (AFHP) - This Framework Agreement is for the supply of Anti D, Four Factor Concentrate and Hyper Immunes (AFHP). The Goods have been split into seven (7) categories, each of which is identified as a "Lot". The Lots are as follows:- Lot 1 - Anti-D (Rho) Immunoglobulin Lot 2 - HBIG Hepatitis B Immunoglobulin Intramuscular use (IM) Lot 3 - HBIG Hepatitis B Immunoglobulin intravenous use (IV) Lot 4 - HTIG Tetanus immunoglobulin intramuscular use (IM) Lot 5 - Anti Rabies immunoglobulin for intramuscular use (IM) Lot 6 - VZIG Varicella - Zoster immunoglobulin intramuscular Lot 7 - Coagulation Factor Four Factor Prothrombin Complex Concentrate (PCC) All deliveries under the framework agreement will be to one central location, namely 'The Scottish National Blood Transfusion Service' (SNBTS), Edinburgh.
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUN285759
  Supply of Anti D, Four Factor Concentrate and Hyper Immunes (AFHP) - Supply of Anti D, Four Factor Concentrate and Hyper Immunes (AFHP). This Framework Agreement has been awarded in seven (7) categories, each of which is identified as a "Lot" as detailed in the contract notice. The Lots are as follows:- Lot 1 - Anti-D (Rho) Immunoglobulin Lot 2 - HBIG Hepatitis B Immunoglobulin Intramuscular use (IM) Lot 3 - HBIG Hepatitis B Immunoglobulin intravenous use (IV) Lot 4 - HTIG Tetanus immunoglobulin intramuscular use (IM) Lot 5 - Anti Rabies immunoglobulin for intramuscular use (IM) Lot 6 - VZIG Varicella - Zoster immunoglobulin intramuscular (IM) Lot 7 - Coagulation Factor Four Factor Prothrombin Complex Concentrate (PCC) All deliveries under the framework agreement will be to one central location, namely 'The Scottish National Blood Transfusion Service' (SNBTS), Edinburgh.

## Notice URLs

- http://
- http://www.nhsscotlandprocurement.scot.nhs.uk/
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000480471
- https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html
- https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.htmlh

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000480471. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000480471.json.